Underexplored Opportunities for Natural Products in Drug Discovery

被引:105
作者
DeCorte, Bart L. [1 ]
机构
[1] Janssen Pharmaceut Co Johnson & Johnson, 1400 McKean Rd, Spring House, PA 19477 USA
关键词
DIVERSITY-ORIENTED SYNTHESIS; OSELTAMIVIR PHOSPHATE TAMIFLU; CELL-CYCLE ARREST; MOLECULAR-CLONING; BIOLOGY; BIOSYNTHESIS; DIOSGENIN; APOPTOSIS; LIBRARY; COMPLEX;
D O I
10.1021/acs.jmedchem.6b00473
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The importance of natural products in the treatment of human disease is well documented. While natural products continue to have a profound impact on human health, chemists have succeeded in generating semisynthetic analogues that sometimes overshadow the original natural product in terms of clinical significance. Synthetic efforts based on natural products have primarily focused on improving their drug-like features while targeting utility in the same biological space. A less documented phenomenon is that natural products can serve as powerful starting materials to generate drug substances with novel therapeutic utility that is unrelated to the biological space of the natural product starting material. In this Perspective, examples of natural product derived marketed drugs with therapeutic utility in clinical space that is different from the biological profile of the starting material are presented, demonstrating that this is not merely a theoretical concept but both a clinical reality and an underexplored opportunity.
引用
收藏
页码:9295 / 9304
页数:10
相关论文
共 108 条
  • [1] MEVINOLIN - A HIGHLY POTENT COMPETITIVE INHIBITOR OF HYDROXYMETHYLGLUTARYL-COENZYME-A REDUCTASE AND A CHOLESTEROL-LOWERING AGENT
    ALBERTS, AW
    CHEN, J
    KURON, G
    HUNT, V
    HUFF, J
    HOFFMAN, C
    ROTHROCK, J
    LOPEZ, M
    JOSHUA, H
    HARRIS, E
    PATCHETT, A
    MONAGHAN, R
    CURRIE, S
    STAPLEY, E
    ALBERSSCHONBERG, G
    HENSENS, O
    HIRSHFIELD, J
    HOOGSTEEN, K
    LIESCH, J
    SPRINGER, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (07): : 3957 - 3961
  • [2] [Anonymous], CHEM PROD CHEM NEWS
  • [3] [Anonymous], HDB EXPT PHARM
  • [4] [Anonymous], AG CLASS IARC MON
  • [5] DAUNOMYCIN .I. STRUCTURE OF DAUNOMYCINONE
    ARCAMONE, F
    BARBIERI, W
    FRANCESC.G
    MONDELLI, R
    OREZZI, P
    CASSINELLI, G
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1964, 86 (23) : 5334 - &
  • [6] The use of isolated natural products as scaffolds for the generation of chemically diverse screening libraries for drug discovery
    Barnes, Emma C.
    Kumar, Rohitesh
    Davis, Rohan A.
    [J]. NATURAL PRODUCT REPORTS, 2016, 33 (03) : 372 - 381
  • [7] Barrett James E, 2002, Mol Interv, V2, P470, DOI 10.1124/mi.2.8.470
  • [8] Recent advances in multicomponent reactions for diversity-oriented synthesis
    Biggs-Houck, James E.
    Younai, Ashkaan
    Shaw, Jared T.
    [J]. CURRENT OPINION IN CHEMICAL BIOLOGY, 2010, 14 (03) : 371 - 382
  • [9] Star role for bacteria in controlling flu pandemic?
    Bradley, D
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2005, 4 (12) : 945 - 946
  • [10] Brahmachari G, 2015, BIOACTIVE NATURAL PRODUCTS: CHEMISTRY AND BIOLOGY, P1